Gainers
- Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 9.9% to $1.0 during Wednesday's after-market session. The company's market cap stands at $15.0 million.
- CNS Pharmaceuticals (NASDAQ:CNSP) stock increased by 8.65% to $0.36. The company's market cap stands at $14.2 million.
- Nuvectis Pharma (NASDAQ:NVCT) shares increased by 8.0% to $10.25. The company's market cap stands at $130.3 million.
- Stealth BioTherapeutics (NASDAQ:MITO) stock increased by 7.81% to $0.45. The company's market cap stands at $26.9 million.
- Eloxx Pharmaceuticals (NASDAQ:ELOX) shares rose 7.48% to $0.35. The company's market cap stands at $30.7 million.
- Exicure (NASDAQ:XCUR) shares rose 7.14% to $0.16. Today's trading volume for this security ended up closing at 175.2K shares, which is 1.2 percent of its average volume over the last 100 days. The company's market cap stands at $19.3 million.
Losers
- Teladoc Health (NYSE:TDOC) shares declined by 35.5% to $36.12 during Wednesday's after-market session. At the close, Teladoc Health's trading volume reached 5.1 million shares. This is 120.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $5.8 billion. As per the news, the Q1 earnings report came out today.
- Sio Gene Therapies (NASDAQ:SIOX) stock declined by 23.72% to $0.46. At the close, Sio Gene Therapies's trading volume reached 141.2K shares. This is 30.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $33.9 million.
- Align Tech (NASDAQ:ALGN) stock declined by 19.55% to $290.0. Today's trading volume for this security ended up closing at 227.8K shares, which is 26.9 percent of its average volume over the last 100 days. The company's market cap stands at $22.8 billion. As per the press release, Q1 earnings came out today.
- Viveve Medical (NASDAQ:VIVE) stock declined by 10.12% to $0.8. The market value of their outstanding shares is at $8.4 million.
- Viking Therapeutics (NASDAQ:VKTX) shares decreased by 8.15% to $2.03. The market value of their outstanding shares is at $157.0 million. As per the press release, Q1 earnings came out today.
- AlloVir (NASDAQ:ALVR) shares declined by 7.82% to $4.13. The market value of their outstanding shares is at $269.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
